Filtered By:
Vaccination: Pneomococcal Vaccine
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 4840 results found since Jan 2013.
Detection of mostly viral pathogens and high proportion of antibiotic treatment initiation in hospitalised children with community-acquired pneumonia in Switzerland - baseline findings from the first two years of the KIDS-STEP trial
CONCLUSIONS: In the context of the predominantly viral pathogens detected, the majority of antibiotic treatment is probably unnecessary. The ongoing trial, as well as other studies, will be able to provide comparative pathogen detection data to compare pre- and post-COVID-19-pandemic settings.PMID:36800889 | DOI:10.57187/smw.2023.40040
Source: Swiss Medical Weekly - February 21, 2023 Category: General Medicine Authors: Malte Kohns Vasconcelos Patrick M Meyer Sauteur Kristina Keitel Regina Santoro Adrian Egli Michael Coslovsky Michelle Seiler Marco Lur à Henrik K öhler Natasha Loevy Christian R Kahlert Ulrich Heininger Johannes Van den Anker Julia A Bielicki Source Type: research
Serotypes and antimicrobial resistance of < em > Streptococcus pneumoniae < /em > in children under 5 years of age pre- and post-pneumococcal conjugate vaccine introduction in Paraguay
Conclusion. A change in the circulating serotypes and antimicrobial resistance to certain antibiotics was observed. Non-vaccine serotype circulation and multidrug resistance may compromise the success of the conjugate vaccines.PMID:37289483 | DOI:10.1099/jmm.0.001700
Source: Journal of Medical Microbiology - June 8, 2023 Category: Microbiology Authors: Mar ía Eugenia León Margarita Samudio An íbal Kawabata Minako Nagai Liliana Rojas Noem í Zárate Juan Irala Myrian Leguizam ón Gloria G ómez Juana Ortellado Raquel Blasco Rossana Franco Gustavo Chamorro Source Type: research
PCV-13 May Not Fully Protect Children With Comorbidity PCV-13 May Not Fully Protect Children With Comorbidity
Among children vaccinated with PCV13, invasive pneumococcal disease is more common in those with comorbidities, suggesting routine vaccination may not be enough to reduce this risk. Medscape Medical News
Source: Medscape Medical News Headlines - July 7, 2014 Category: Consumer Health News Tags: Pediatrics News Source Type: news
U.S. Advisory Panel Recommends Prevnar 13 Vaccine for ElderlyU.S. Advisory Panel Recommends Prevnar 13 Vaccine for Elderly
An influential U.S. medical advisory panel recommended that people 65 and older be given Pfizer Inc's blockbuster Prevnar 13 vaccine to protect against pneumococcal bacteria that can cause pneumonia and other infections. Reuters Health Information
Source: Medscape Medical News Headlines - August 14, 2014 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Pneumococcal Vaccine Reduces Hospitalization RatesPneumococcal Vaccine Reduces Hospitalization Rates
Young children's hospitalizations for sinusitis and pneumonia decreased in the years after pneumococcal vaccine introduction in Sweden. Medscape Medical News
Source: Medscape Medical News Headlines - November 10, 2014 Category: Consumer Health News Tags: Pediatrics News Source Type: news
